Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Sex Based Pharmacological Treatment in Patients With Metabolic Syndrome: Findings From the Isfahan Healthy Heart Program Publisher



Gharipour M1 ; Kelishadi R2 ; Toghianifar N2 ; Mackie M3 ; Yazdani M2 ; Noori F4 ; Sarrafzadegan N2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Biochemistry, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Centre for Neuroscience, University of Alberta, Canada
  4. 4. Statistical sciences, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

Source: African Journal of Pharmacy and Pharmacology Published:2011


Abstract

Pharmacological therapy is a critical step in the management of individuals with the metabolic syndrome (MetS) when lifestyle modifications cannot achieve the therapeutic goals. However, it has been well-documented that there is no single best therapy other than weight loss, and that treatment should be targeted at individual components of the MetS. The objective of this study was to investigate the treatment of individual components of the MetS in a population-based sample of individuals with clustering MetS components. In a cross-sectional population-based survey, we studied a randomly collected sample of men and women who had participated in the baseline survey of a community-based program in three Central Iranian counties in 2000 to 2001. Demographic data, medical status, and drug history were obtained by questionnaire. We evaluated the association between clustering of the MetS components and pharmacological treatment of cardiovascular risk factors. The most common pharmacologic agents prescribed for individuals with the MetS were beta-blockers (72.8%), followed by lipid-lowering agents (36%) with no significant gender difference. A high level of compliance with drug treatment was noted. Further research is warranted to understand the compliance behavior of patients with the MetS. © 2011 Academic Journals.
Related Docs
View other Related Docs
1. The Pattern of Pharmacological Treatment in Subjects With Metabolic Syndrome: Findings From Isfahan Healthy Heart Program, Journal of Isfahan Medical School (2011)
2. The Impact of a Community Trial on the Pharmacological Treatment in the Individuals With the Metabolic Syndrome: Findings From the Isfahan Healthy Heart Program, 2001-2007, Archives of Medical Science (2012)
3. Does the Impact of Metabolic Syndrome on Cardiovascular Events Vary by Using Different Definitions? Chronic Disease Epidemiology, BMC Public Health (2015)
4. Socioeconomic Disparities and Smoking Habits in Metabolic Syndrome: Evidence From Isfahan Healthy Heart Program, Iranian Red Crescent Medical Journal (2011)
5. Appropriate Cut-Off Values of Waist Circumference to Predict Cardiovascular Outcomes: 7-Year Follow-Up in an Iranian Population, Internal Medicine (2012)
6. Determinants of Changes in Metabolic Syndrome Components in a 12-Year Cohort of Iranian Adults, Metabolic Syndrome and Related Disorders (2019)
7. Anxiety But Not Depression Is Associated With Metabolic Syndrome: The Isfahan Healthy Heart Program, Journal of Research in Medical Sciences (2017)
8. The Impact of Obesity on Hypertension and Diabetes Control Following Healthy Lifestyle Intervention Program in a Developing Country Setting, Journal of Research in Medical Sciences (2011)
Experts (# of related papers)
View all Related Experts
Nizal Sarrafzadegan (119)
Roya Kelishadi (87)
Other Related Docs
9. Apopulation-Based Metabolic Syndrome Risk Score and Its Determinants: The Isfahan Healthy Heart Program, Journal of Research in Medical Sciences (2014)
10. First Nationwide Study of the Prevalence of the Metabolic Syndrome and Optimal Cutoff Points of Waist Circumference in the Middle East: The National Survey of Risk Factors for Noncommunicable Diseases of Iran, Diabetes Care (2009)
11. Relationship Between Legumes Consumption and Metabolic Syndrome: Findings of the Isfahan Healthy Heart Program, ARYA Atherosclerosis (2014)
12. Metabolic Syndrome and Health-Related Quality of Life in Iranian Population, Journal of Research in Medical Sciences (2011)
13. Outcomes of a Comprehensive Healthy Lifestyle Program on Cardiometabolic Risk Factors in a Developing Country: The Isfahan Healthy Heart Program, Archives of Iranian Medicine (2013)
14. Metabolic Syndrome in Iranian Elderly, ARYA Atherosclerosis (2012)
15. Relationship Between Metabolic Syndrome and Its Components With Psychological Distress, International Journal of Endocrinology (2014)
16. Impact of Metabolic Syndrome on Ischemic Heart Disease - a Prospective Cohort Study in an Iranian Adult Population: Isfahan Cohort Study, Nutrition, Metabolism and Cardiovascular Diseases (2012)
17. Metabolic Syndrome: An Emerging Public Health Problem in Iranian Women: Isfahan Healthy Heart Program, International Journal of Cardiology (2008)
18. Association Between Sleep Duration and Metabolic Syndrome in a Population-Based Study: Isfahan Healthy Heart Program, Journal of Research in Medical Sciences (2011)
19. How Does the Impact of a Community Trial on Cardio-Metabolic Risk Factors Differ in Terms of Gender and Living Area? Findings From the Isfahan Healthy Heart Program, Journal of Research in Medical Sciences (2012)
20. Incident Hypertension and Its Predictors: The Isfahan Cohort Study, Journal of Hypertension (2014)
21. Prevalence of Metabolic Syndrome and Its Components in the Iranian Adult Population: A Systematic Review and Meta-Analysis, Iranian Red Crescent Medical Journal (2015)
22. Association of Glycaemic Index and Glycaemic Load With Metabolic Syndrome in an Iranian Adult Population: Isfahan Healthy Heart Program, Nutrition and Dietetics (2017)
23. Isfahan Healthy Heart Program, Sample Size and Sampling Structure: A Comprehensive Report, Journal of Isfahan Medical School (2016)
24. Prevalence of Metabolic Syndrome According to Atpiii and Idf Criteria in the Iranian Population, Koomesh (2012)
25. The Relationship Between Hematologic Variables and Metabolic Syndrome, Iranian Heart Journal (2011)
26. Metabolic Syndrome in Menopausal Transition: Isfahan Healthy Heart Program, a Population Based Study, Diabetology and Metabolic Syndrome (2010)
27. The Effect of Moderate Substitution of Dietary Carbohydrates by Fats on Serum Levels of Adipocytokines, Inflammatory Indices, and Biomarkers of Endothelial Function Amongwomen With Metabolic Syndrome, Journal of Zanjan University of Medical Sciences and Health Services (2012)
28. Stress As a Risk Factor for Noncompliance With Treatment Regimens in Patients With Diabetes and Hypertension, ARYA Atherosclerosis (2016)
29. Determinants of Weight Change in a Longitudinal Study of Iranian Adults: Isfahan Cohort Study, Archives of Iranian Medicine (2014)
30. Metabolic Syndrome and the Risk of Ischemic Stroke, Journal of Stroke and Cerebrovascular Diseases (2017)
31. Comparative Effects of Carbohydrate Versus Fat Restriction on Serum Levels of Adipocytokines, Markers of Inflammation, and Endothelial Function Among Women With the Metabolic Syndrome: A Randomized Cross-Over Clinical Trial, Annals of Nutrition and Metabolism (2013)
32. Left Ventricular Diastolic Function in Subjects With Metabolic Syndrome: Isfahan Cohort Study, Iranian Heart Journal (2013)
33. Sex Based Levels of C-Reactive Protein and White Blood Cell Count in Subjects With Metabolic Syndrome: Isfahan Healthy Heart Program, Journal of Research in Medical Sciences (2013)
34. Evaluation of Heart Rate Reserve and High-Sensitivity C-Reactive Protein in Individuals With and Without Metabolic Syndrome in Isfahan, Iran, ARYA Atherosclerosis (2012)
35. Multiparity and Risk of Metabolic Syndrome: Isfahan Healthy Heart Program, Metabolic Syndrome and Related Disorders (2009)
36. Assessing Body Shape Index As a Risk Predictor for Cardiovascular Diseases and Metabolic Syndrome Among Iranian Adults, Nutrition (2014)
37. Consumption of Sugar-Sweetened Beverages in Relation to the Metabolic Syndrome Among Iranian Adults, Obesity Facts (2012)
38. The Effects of a Comprehensive Community Trial on Cardiometabolic Risk Factors in Adolescents: Isfahan Healthy Heart Program, ARYA Atherosclerosis (2012)
39. Evaluating the Relation Between Metabolic Syndrome and Its Components With Low Ankle to Brachial Index in an Iranian Population, Journal of Isfahan Medical School (2011)
40. Is the Association Between Vitamin D and Metabolic Syndrome Independent of Other Micronutrients?, International Journal for Vitamin and Nutrition Research (2015)
41. Methods of Sampling and Sample Size Determination of a Comprehensive Integrated Community-Based Interventional Trial: Isfahan Healthy Heart Program, ARYA Atherosclerosis (2018)
42. Adherence to Healthy Eating Index-2010 Is Inversely Associated With Metabolic Syndrome and Its Features Among Iranian Adult Women, European Journal of Clinical Nutrition (2017)
43. The Effect of Educational and Encouragement Interventions on Anthropometric Characteristics, Obestatin and Adiponectin Levels, ARYA Atherosclerosis (2019)
44. The Metabolic Syndrome in Hypertensive and Normotensive Subjects: The Isfahan Healthy Heart Programme, Annals of the Academy of Medicine Singapore (2005)
45. The Association Between Dietary Habits and Metabolic Syndrome: Findings From the Shahedieh-Cohort Study, BMC Nutrition (2022)
46. Longitudinal Association of Metabolic Syndrome and Dietary Patterns: A 13-Year Prospective Population-Based Cohort Study, Nutrition, Metabolism and Cardiovascular Diseases (2018)
47. Adherence to a Healthy Diet and Odds of Metabolic Syndrome: A Cross-Sectional Study, Clinical Nutrition ESPEN (2023)
48. Low-Carbohydrate-Diet Score and Metabolic Syndrome: An Epidemiologic Study Among Iranian Women, Nutrition (2015)
49. The Effect of a Moderately Restricted Carbohydrate Diet on Cardiometabolic Risk Factors in Overweight and Obese Women With Metabolic Syndrome: A Randomized Controlled Trial, Clinical Therapeutics (2023)
50. Metabolic Syndrome and Associated Factors in Iranian Children and Adolescents: The Caspian-V Study, Journal of Cardiovascular and Thoracic Research (2018)